|
1
|
Yan Y, Yang FQ, Zhang HM, Che J and Zheng
JH: Up-regulation of flotillin-2 is associated with renal cell
carcinoma progression. Tumour Biol. 35:10479–10486. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Patel C, Ahmed A and Ellsworth P: Renal
cell carcinoma: A reappraisal. Urol Nurs. 32:182–190; quiz 191.
2012.PubMed/NCBI
|
|
3
|
Du M, Lu D, Wang Q, Chu H, Tong N, Pan X,
Qin C, Yin C, Wang M and Zhang Z: Genetic variations in microRNAs
and the risk and survival of renal cell cancer. Carcinogenesis.
35:1629–1635. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yin B, Zeng Y, Wang X, Liu G, Zhang M and
Song Y: Expression and clinical significance of cancer-testis genes
in clear cell renal cell carcinoma. Int J Clin Exp Pathol.
7:4112–4119, eCollection 2014. 2014.PubMed/NCBI
|
|
6
|
Rasmussen F: Metastatic renal cell cancer.
Cancer Imaging. 13:374–380. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tostain J, Li G, Gentil-Perret A and
Gigante M: Carbonic anhydrase 9 in clear cell renal cell carcinoma:
A marker for diagnosis, prognosis and treatment. Eur J Cancer.
46:3141–3148. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Singh P, Agarwal N and Pal SK: Sequencing
systemic therapies for metastatic kidney cancer. Curr Treat Options
Oncol. 16:3162015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu M, Tang Q, Qiu M, Lang N, Li M, Zheng
Y and Bi F: miR-21 targets the tumor suppressor RhoB and regulates
proliferation, invasion and apoptosis in colorectal cancer cells.
FEBS Lett. 585:2998–3005. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang W, Li J, Zhu W, Gao C, Jiang R, Li W,
Hu Q and Zhang B: MicroRNA-21 and the clinical outcomes of various
carcinomas: A systematic review and meta-analysis. BMC Cancer.
14:8192014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhou X, Wang X, Huang Z, Wang J, Zhu W,
Shu Y and Liu P: Prognostic value of miR-21 in various cancers: An
updating meta-analysis. PloS One. 9:e1024132014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pernaute B, Spruce T, Smith KM,
Sánchez-Nieto JM, Manzanares M, Cobb B and Rodríguez TA: MicroRNAs
control the apoptotic threshold in primed pluripotent stem cells
through regulation of BIM. Genes Dev. 28:1873–1878. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhou J, Jiang Z, Wang Z, et al:
MicroRNA-142-3p is frequently upregulated in colorectal cancer and
may be involved in the regulation of cell proliferation. Chinese
Science Bulletin. 58:2836–2845. 2013. View Article : Google Scholar
|
|
14
|
Xu Y, Brenn T, Brown ER, Doherty V and
Melton DW: Differential expression of microRNAs during melanoma
progression: MiR-200c, miR-205 and miR-211 are downregulated in
melanoma and act as tumour suppressors. Br J Cancer. 106:553–561.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shibuya H, Iinuma H, Shimada R, Horiuchi A
and Watanabe T: Clinicopathological and prognostic value of
microRNA-21 and microRNA-155 in colorectal cancer. Oncology.
79:313–320. 2010. View Article : Google Scholar
|
|
16
|
Shenouda SK and Alahari SK: MicroRNA
function in cancer: Oncogene or a tumor suppressor? Cancer
Metastasis Rev. 28:369–378. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhai Z, Wu F, Dong F, Chuang AY, Messer
JS, Boone DL and Kwon JH: Human autophagy gene ATG16L1 is
post-transcriptionally regulated byMIR142-3p. Autophagy.
10:468–479. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang C, Yao C, Li H, Wang G and He X:
Combined elevation of microRNA-196a and microRNA-196b in sera
predicts unfavorable prognosis in patients with osteosarcomas. Int
J Mol Sci. 15:6544–6555. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Slater EP, Strauch K, Rospleszcz S,
Ramaswamy A, Esposito I, Klöppel G, Matthäi E, Heeger K, Fendrich
V, Langer P and Bartsch DK: MicroRNA-196a and -196b as potential
biomarkers for the early detection of familial pancreatic cancer.
Transl Oncol. 7:464–471. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tsai MM, Wang CS, Tsai CY, Chen CY, Chi
HC, Tseng YH, Chung PJ, Lin YH, Chung IH, Chen CY and Lin KH:
MicroRNA-196a/-196b promote cell metastasis via negative regulation
of radixin in human gastric cancer. Cancer Lett. 351:222–231. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yi Z, Fu Y, Zhao S, Zhang X and Ma C:
Differential expression of miRNA patterns in renal cell carcinoma
and nontumorous tissues. J Cancer Res Clin Oncol. 136:855–862.
2010. View Article : Google Scholar
|
|
22
|
White NM, Khella HW, Grigull J, Adzovic S,
Youssef YM, Honey RJ, Stewart R, Pace KT, Bjarnason GA, Jewett MA,
et al: miRNA profiling in metastatic renal cell carcinoma reveals a
tumour-suppressor effect for miR-215. Br J Cancer. 105:1741–1749.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Edge S, Byrd DR, Compton C, Fritz A,
Greene FL and Trotti A: AJCC Cancer Staging Manual. 7th edition.
Springer; New York, NY: 2010
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
25
|
Luo J, Cai Q, Wang W, Huang H, Zeng H, He
W, Deng W, Yu H, Chan E, Ng CF, et al: A microRNA-7 binding site
polymorphism in HOXB5 leads to differential gene expression in
bladder cancer. PloS One. 7:e401272012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Juan D, Alexe G, Antes T, Liu H,
Madabhushi A, Delisi C, Ganesan S, Bhanot G and Liou LS:
Identification of a microRNA panel for clear-cell kidney cancer.
Urology. 75:835–841. 2010. View Article : Google Scholar
|
|
27
|
Wang S, Hu J, Zhang D, Li J, Fei Q and Sun
Y: Prognostic role of microRNA-31 in various cancers: A
meta-analysis. Tumor Biol. 35:11639–11645. 2014. View Article : Google Scholar
|
|
28
|
Suh YE, Raulf N, Güken J, Lawler K, Urbano
TG, Bullenkamp J, Gobeil S, Huot J, Odell E and Tavassoli M:
MicroRNA-196a promotes an oncogenic effect in head and neck cancer
cells by suppressing annexin A1 and enhancing radioresistance. Int
J Cancer. 137:1021–1034. 2015. View Article : Google Scholar
|
|
29
|
Pazzaglia L, Leonardi L, Conti A, Novello
C, Quattrini I, Montanini L, Roperto F, Del Piero F, Di Guardo G,
Piro F, et al: miR-196a expression in human and canine
osteosarcomas: A comparative study. Res Vet Sci. 99:112–119. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hong TH and Park IY: MicroRNA expression
profiling of diagnostic needle aspirates from surgical pancreatic
cancer specimens. Ann Surg Treat Res. 87:290–297. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu XH, Lu KH, Wang KM, Sun N, Zhang EB,
Yang JS, Yin DD, Liu ZL, Zhou J, Liu ZJ, et al: MicroRNA-196a
promotes non-small cell lung cancer cell proliferation and invasion
through targeting HOXA5. BMC Cancer. 12:3482012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sun M, Liu XH, Li JH, Yang JS, Zhang EB,
Yin DD, Liu ZL, Zhou J, Ding Y, Li SQ, et al: MiR-196a is
upregulated in gastric cancer and promotes cell proliferation by
downregulating p27 (kip1). Mol Cancer Ther. 11:842–852. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang J, Chen J, Chang P, LeBlanc A, Li D,
Abbruzzesse JL, Frazier ML, Killary AM and Sen S: MicroRNAs in
plasma of pancreatic ductal adenocarcinoma patients as novel
blood-based biomarkers of disease. Cancer Prev Res (Phila).
2:807–813. 2009. View Article : Google Scholar
|
|
34
|
Aso T, Ohtsuka T, Tamura K, Ideno N, Kono
H, Nagayoshi Y, Ohuchida K, Ueda J, Takahata S, Shindo K, et al:
Elevated expression level of microRNA-196a is predictive of
intestinal-type intraductal papillary mucinous neoplasm of the
pancreas. Pancreas. 43:361–366. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ge J, Chen Z, Li R, Lu T and Xiao G:
Upregulation of microRNA-196a and microRNA-196b cooperatively
correlate with aggressive progression and unfavorable prognosis in
patients with colorectal cancer. Cancer Cell Int. 14:1282014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang W, Zhang C, Chen H, Li L, Tu Y, Liu
C, Shi S, Zen K and Liu Z: Evaluation of microRNAs miR-196a,
miR-30a-5P and miR-490 as biomarkers of disease activity among
patients with FSGS. Clin J Am Soc Nephrol. 9:1545–1552. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kim YJ, Bae SW, Yu SS, Bae YC and Jung JS:
miR-196a regulates proliferation and osteogenic differentiation in
mesenchymal stem cells derived from human adipose tissue. J Bone
Miner Res. 24:816–825. 2009. View Article : Google Scholar
|
